What is Nivolumab?

Category: Prescription Drugs

Most popular types: Opdivo

false

Nivolumab is an injectable medication that works with your body's immune system to fight certain types of cancer. It may be used for the treatment of some types of melanoma and non-small cell lung cancer.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Adenocarcinoma (non-small cell lung cancer) 10 6
Squamous cell carcinoma (non-small cell lung cancer) 6 5
Non-small cell lung cancer 4 2
Small cell lung cancer 2 2
Adenosquamous carcinoma (non-small cell lung cancer) 1 1
Melanoma 1 0

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 2
Mild 6
None 6

Commonly reported side effects and conditions associated with Nivolumab

Side effect Patients
Fatigue 2
Joint pain 2
Blurry vision 1
Chills 1
Elevated liver enzymes 1
Frequent urination 1

Show all 22 reported side effects

Dosages

Based on patients currently taking Nivolumab

Dosage Patients
10 mg every other week 6
10 mg every 3 weeks 1
20 mg every other week 1
240 mg every other week 1
240 other every other week 1
3,470 mg every other week 1

Why patients stopped taking Nivolumab

Multiple reasons could be selected

Reason Patients
Other 2
See all 2 patients who've stopped taking Nivolumab

Duration

Currently taking Nivolumab

Duration Patients
6 months - 1 year 6
1 - 2 years 5
2 - 5 years 3

Stopped taking Nivolumab

Duration Patients
1 - 6 months 1
1 - 2 years 1
Adherence
Adherence Evaluations
Always 15
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 3
A little hard to take 1
Not at all hard to take 11
Cost per month
Cost per month Evaluations
$200+ 3
$100-199 1
$50-99 1
$25-49 0
< $25 5
Not specified 5

What people switch to and from

Patients started taking Nivolumab after stopping:

Treatment Patients
Chemotherapy 12
Bevacizumab (Avastin) 1
Carboplatin 1
Paclitaxel (Taxol) 1

Patients stopped taking Nivolumab and switched to:

Treatment Patients
Ipilimumab (Yervoy) 1
Last updated:
There are no evaluations for Nivolumab.